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The South African government’s recent policy decision to 
expand access to HIV care rapidly and ‘ensure that all the 
health institutions in the country are ready to receive and assist 
patients and not just a few accredited ARV centres’1 represents 
a dramatic and welcome about-turn on years of hesitation and 
confusion in the country’s response to the HIV epidemic. In 
the first 6 years of the antiretroviral therapy (ART) programme, 
approximately 900 000 people have been started on treatment. 
In the next 2 - 3 years, the government proposes to initiate 
treatment in another 1.2 million people.2 The medical and 
moral imperative for providing this life-saving treatment to 
all who need it does not need to be defended, but the limited 
capacity of the public health sector to achieve this scale of 
increase raises serious questions about the practicality of this 
objective. Along with raising the CD4 thresholds for access to 
treatment and scrapping the antiretroviral site accreditation 
process, nurse initiation and management of patients on ART 
(NIM-ART) is under discussion at the national level as a key 
strategy for expanding access. There are simply not enough 
doctors in the public sector to introduce and follow up this 
number of patients. The major load from this increase will 
therefore have to be shifted to nurses, themselves under severe 
pressure and in short supply. 
Broadening the ART delivery platform to include nurses has 
been debated at the national level for several years. However, 
the discussion has focused on understanding the legal and 
regulatory frameworks that govern nurse prescribing, and little 
attention has been paid to how to implement NIM-ART. The 
legal difficulties are, in fact, minimal – the Minister of Health 
can simply authorise nurse prescription of ART in line with the 
Medicines Control Act. Rather, the key questions that should 
concern policymakers and practitioners are whether NIM-ART 
will provide the solution to expanding access to antiretrovirals, 
and how effective and sustainable it will be. Further, what 
systems and resources will be required to make it work, and 
what impact will this major push have on the health system 
and the broader health needs of the country? 
Current evidence around nurse-initiated ART
Although task-shifting is widely promoted as the solution 
to expanding ART access,3-6 the evidence for non-physician-
provided ART in Africa is limited. Few studies have compared 
the performance of non-physicians with doctors,7-12 and 
only three have been randomised.7-9 Although incompletely 
described, the interventions studied invariably do not reflect 
what might be feasible within the constraints typical of 
public sector care, with all having benefited from intensive 
training and support from predominantly overseas-funded 
non-governmental organisations. Further, in these studies 
non-physician care is restricted to the monitoring of patients 
already on treatment, with initiation usually being performed 
by study physicians. Under these conditions, all studies 
reported equivalent ART treatment outcomes, including viral 
load suppression, mortality and retention in care. 
Field reports from programmes that have used non-
physicians to deliver ART, including from rural settings in 
South Africa, are more plentiful and report similarly positive 
(although less reliable) results in terms of both ART outcomes 
and improved access.13-20 Again, however, these programmes 
benefitted from either substantial NGO support or visionary 
and committed leadership, or both. Such resources are not 
available to the rapid national scale-up required to meet the 
ambitious targets set by government.
Developing evidence around complex health interventions – 
such as a particular model for the delivery of ART treatment – 
is difficult in the best of circumstances, but critical. Consider 
the directly observed treatment (DOT) approach for TB: 
implemented globally before robust evidence was available, 
a systematic review of 11 randomised controlled trials now 
shows it to be no more effective than self-supervised treatment 
in improving TB treatment outcomes.21 
Evidence is limited that NIM-ART can expand access safely 
and efficiently at scale. We know that nurses can initiate and 
manage patients on ART successfully – on this count ART is no 
different from other clinical tasks nurses routinely undertake. 
However, we don’t know enough about how to implement 
NIM-ART programmes effectively, including the key barriers 
and enablers at patient, provider and organisational levels.
Lessons from the STRETCH trial in the Free State 
An ongoing trial being conducted in the Free State – the 
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for HIV (STRETCH) trial – attempts to address some of these 
gaps in the evidence.22 STRETCH is evaluating the effect of 
NIM-ART on ART access (by comparing mortality among 
patients eligible for treatment), and on quality of ART care 
(by comparing viral load suppression rates in those receiving 
ART). It is a pragmatic trial that is being implemented within 
all the usual constraints of the public health system, including 
the much-publicised difficulties with maintaining ART supplies 
during late 2008 and 2009.23 
A key component of STRETCH is the use of ART initiation 
guidelines tailored specifically to nurses. These guidelines are 
based on the successful PALSA PLUS guidelines that have 
been shown to improve the quality of respiratory and HIV care 
provided by nurses.24-26  They provide clear clinical criteria for 
referral of complex cases to a doctor. The trial intervention is 
composed of three phases – training on the guidelines, nurse 
re-prescription, and finally, nurse initiation.
Quantitative outcomes for STRETCH will be available 
during the second half of 2010. But provisional findings from a 
qualitative process evaluation that has been running parallel to 
the trial raise a number of important points that should inform 
rapid national roll-out of NIM-ART. 
The good news is that our research confirms that NIM-ART 
is highly acceptable among nurses, patients and doctors, and 
that managers and nurses expressed confidence in their ability 
to apply the guidelines and deliver ART successfully. This 
confidence developed slowly, however, through a phased and 
well-supported approach that guided nurses through training, 
re-prescription and initiation. Key to building and sustaining 
that confidence were two things: firstly, ongoing clinical 
support from a range of sources including doctors, district 
ARV co-ordinators, STRETCH trainers, and experienced fellow 
nurses, and, secondly, clear criteria for the referral of more 
complex cases. Such referral criteria are used routinely in the 
nurse management of other diseases, such as tuberculosis and 
hypertension.27,28 
However, the qualitative research has also revealed 
that increasing access through nurse initiation results in 
significant knock-on effects in terms of training and support 
needs, workload and capacity constraints, logistical and 
infrastructural challenges, and shifts in the working and 
referral relationships between health staff. Importantly, these 
effects were not only felt among nurses and doctors but also 
among pharmacists, lay counsellors, data capturers and health 
managers. Decentralising ART to all facilities in the country 
will entail a significant re-organisation of workloads and 
relationships between different levels of care. These findings 
add to those from our northern neighbours and suggest that 
NIM-ART, as a complex health system intervention, involves 
far more extensive challenges than simply training up nurses, 
managing workloads and paying for the higher drug bill.5,29
In summary, the emerging evidence from the STRETCH trial 
suggests that NIM-ART is feasible and acceptable in the public 
sector, but these findings are based on an intervention model 
that: (i) uses an incremental approach to implementation, 
including an initial phase of external training and support; and 
(ii) is based on clinical guidelines tailored to nurses at different 
levels of care.
Translating evidence into policy and practice
What do these findings mean for the anticipated roll-out of 
NIM-ART in April 2010? Proponents of a rapid, national roll-
out of NIM-ART argue that the needs of the country demand a 
drastic response, that a rare political space for decisive action 
in the health system has finally opened up, and that phasing 
in NIM-ART or offering nurses clear criteria for referral of 
complex cases will only serve to create bottlenecks and reduce 
access. This is a compelling argument, both from a moral 
point of view and in terms of the universal tendency of state 
bureaucracies to avoid change, promote inefficiencies and 
maintain entrenched habits and hierarchies. 
The available evidence, however, points to NIM-ART being a 
potentially effective, sustainable and acceptable approach, but 
one that also entails significant stresses and realignments in 
the health system. The STRETCH qualitative research findings, 
along with the wider international literature on scaling up,30 
point to the potential dangers of a too-rapid roll-out that does 
not build incrementally the capacity, confidence, co-ordination 
and support needed to implement NIM-ART at scale. There is 
a risk that nurses will be left to shoulder the ongoing burden 
of rapid expansion without adequate training or support, and 
within a health system already under considerable strain.31 
Several years of studying and supporting task shifting and 
guideline-driven care in primary care nursing have provided 
evidence for the ways to manage these significant changes 
in the health system and avoid the most obvious pitfalls. 
Along with basic training and support and an appropriately 
phased implementation, guidelines that are designed for 
and specific to nurses and that clarify referral options are an 
important component in the development of long-term clinical 
confidence and competence in NIM-ART. Our work suggests 
that nurses in the Free State accepted the significant increases 
in workload with NIM-ART because they felt adequately 
prepared and supported, and because they felt empowered by 
the opportunity to save patients who would have died without 
treatment access.25,32 
Come April, the combination of decisive leadership, political 
will and an expanded delivery platform has the potential to 
accelerate ART access in our country like never before. But 
the complexity and risks this may present to the backbone 
of our public health sector, nurse-led primary care, must be 
recognised and addressed and all tested strategies employed to 
ensure that the system is strengthened and not undermined. 
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